electroCore Announces Two New Studies and a Publication Supporting the Practical Utility of Non-invasive Vagus Nerve Stimulation in Adults

NEXT STORY
Caprion Biosciences Offers Mass Cytometry CRO Services to Advance Biomarker Discovery and Immune Monitoring
PREV STORY
Global In-vitro Diagnostics Market Report 2019-2023: Market will Register a CAGR of Almost 7% – Adoption of Advanced Treatment Solutions to Gain Traction
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Scilex Holding Company, a Sorrento Therapeutics, Inc. Subsidiary, Announces Highly Significant Positive Top-Line Results from its Phase 3 Non-Opioid Injectable SP-102 (SEMDEXA™) Pivotal Trial C.L.E.A.R. Program for Sciatica Pain Management Supporting the Potential Use of SP-102 as a Best-in-Class Therapy

author_avatar
NASDAQ Market News

Alignment Healthcare Enters into Agreement with CareMore Health, Adding More Than 3,000 Providers to its 2022 Provider Network in Arizona and Nevada

author_avatar
NASDAQ Market News

Takeda and Ovid Therapeutics Expand Clinical Program for TAK-935/OV935 with Three New Studies in Rare Developmental and Epileptic Encephalopathies (DEE)

Broad clinical program to include three studies expected to begin in the third quarter ...

author_avatar
NASDAQ Market News